Iwata Masahiro, Kasagi Kanji, Hatabu Hiroto, Misaki Takashi, Iida Yasuhiro, Fujita Toru, Konishi Junji
Department of Radiology, Hikone Municipal Hospital, Honmachi, Shiga, Japan.
Ann Nucl Med. 2002 Jun;16(4):279-87. doi: 10.1007/BF03000108.
This study was done retrospectively to analyze the ultrasonographic (US) findings in thyroid scintigraphic hot areas (HA). Three-thousand, eight-hundred and thirty-nine consecutive patients who underwent 99mTc-pertechnetate (n = 3435) or 123I (n = 457) scintigraphy were analyzed. HA were regarded as present when the tracer concentration was greater than the remaining thyroid tissue, or when hemilobar uptake was observed. High-resolution US examinations were performed with a real-time electronic linear scanner with a 7.5 or 10 MHz transducer. One hundred and four (2.7%) were found to be scintigraphic HA (n = 120). US revealed a nodular lesion or well-demarcated thyroid tissue corresponding to the HA in 94 areas (78.4%, Category 1), an ill-defined region with different echogenicity in 13 areas (10.8%, Category 2), and no correlating lesion in 13 areas (10.8%, Category 3). These 104 patients included 43 with adenomatous goiter (59 areas), 33 with adenoma, 11 with Hashimoto's thyroiditis, 5 with primary thyroid cancer, 4 with euthyroid ophthalmic Graves' disease (EOG), 3 with hemilobar atrophy or hypogenesis, 2 with hemilobar agenesis, 2 with hypothyroidism with blocking-type TSH-receptor antibodies (TSHRAb), I with acute suppurative thyroiditis. Among the 59 adenomatous nodules and 33 adenomas, 51 (86.4%) and 32 (97.0%), respectively, belonged to Category 1. A solitary toxic nodule was significantly larger and occurs more often in older patients than in younger patients. On the other hand, all 17 patients with known autoimmune thyroid diseases including Hashimoto's thyroiditis, EOG and hypothyroidism with blocking TSHRAb belonged to Category 2 or 3. Possible underlying mechanisms are 1) hyperfunctioning tumors or nodules, 2) localized functioning thyroid tissue freed from autoimmune destruction, inflammation or tumor invasion, 3) congenital abnormality, 4) clusters of hyperactive follicular cells caused by long-term TSH and/or TSHRAb stimulation, 5) asymmetry, etc. Scintigraphic HA are observed in patients with various thyroid diseases and high-resolution US appears to be helpful clinically for the differential diagnosis of the above mentioned disorders.
本研究采用回顾性分析甲状腺闪烁扫描热区(HA)的超声(US)表现。对3839例连续接受高锝[99mTc]酸盐(n = 3435)或碘[123I](n = 457)闪烁扫描的患者进行分析。当示踪剂浓度高于其余甲状腺组织,或观察到半叶摄取时,则视为存在HA。使用配备7.5或10 MHz探头的实时电子线性扫描仪进行高分辨率US检查。发现104例(2.7%)为闪烁扫描HA(n = 120)。US显示94个区域(78.4%,1类)有与HA相对应的结节性病变或边界清晰的甲状腺组织,13个区域(10.8%,2类)有回声不均匀的边界不清区域,13个区域(10.8%,3类)无相关病变。这104例患者包括43例腺瘤性甲状腺肿(59个区域)、33例腺瘤、11例桥本甲状腺炎、5例原发性甲状腺癌、4例甲状腺功能正常的Graves眼病(EOG)、3例半叶萎缩或发育不全、2例半叶缺如、2例伴有阻断型促甲状腺激素受体抗体(TSHRAb)的甲状腺功能减退症、1例急性化脓性甲状腺炎。在59个腺瘤性结节和33个腺瘤中,分别有51个(86.4%)和32个(97.0%)属于1类。孤立性毒性结节明显更大,且在老年患者中比在年轻患者中更常见。另一方面,包括桥本甲状腺炎、EOG和伴有阻断TSHRAb的甲状腺功能减退症在内的所有17例已知自身免疫性甲状腺疾病患者均属于2类或3类。可能的潜在机制为:1)功能亢进的肿瘤或结节;2)免受自身免疫破坏、炎症或肿瘤侵犯的局部功能性甲状腺组织;3)先天性异常;4)长期促甲状腺激素和/或TSHRAb刺激导致的高活性滤泡细胞簇;5)不对称等。各种甲状腺疾病患者均可观察到闪烁扫描HA,高分辨率US在临床上似乎有助于上述疾病的鉴别诊断。